Semper Paratus regains Nasdaq MVLS compliance effective Sept 28, 2023

Tevogen Bio Holdings Inc.

Company received Nasdaq letter Sept 28, 2023 confirming regained compliance with MVLS Rule (minimum $50M market value).
Non-compliance notice received April 7, 2023; initial cure period ran to Oct 2, 2023.
MVLS exceeded $50M for ten consecutive business days from Sept 14 to Sept 27, 2023.
Compliance regained; delisting risk from Nasdaq Global Market is removed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.